ON-SITE SAMPLING WITH PRECONCENTRATION FOR TRACE METAL ANALYSIS OF NATURAL WATERS Dahkki Meranger, J.C., Subramanian, K.S., Langford, C.H.

Viečča ollesdeavstta

Outpatient assessment of systemic vasculitis. Dahkki Nataraja, A, Mukhtyar, C, Hellmich, B, Langford, C, Luqmani, R

Gene expression profiling in polycythemia vera using cDNA microarray technology. Dahkki Pellagatti, A, Vetrie, D, Langford, C, Gama, S, Eagleton, H, Wainscoat, J, Boultwood, J

GLOBAL GENE EXPRESSION PROFILING REVEALS KEY PATHWAYS ASSOCIATED WITH THE HOST RESPONSE TO CARDIAC SURGERY AND CARDIOPULMONARY BYPASS Dahkki Svoren, E, Radhakrisnan, J, Ellis, P, Langford, C, Mcalees, E, Knight, J, Hinds, C

Genetics of gene expression in primary immune cells identifies cell type-specific master regulators and roles of HLA alleles Dahkki Fairfax, B, Makino, S, Radhakrishnan, J, Plant, K, Leslie, S, Dilthey, A, Ellis, P, Langford, C, Vannberg, F, Knight, J

Genetics of gene expression in primary immune cells identifies cell type-specific master regulators and roles of HLA alleles. Dahkki Fairfax, B, Makino, S, Radhakrishnan, J, Plant, K, Leslie, S, Dilthey, A, Ellis, P, Langford, C, Vannberg, F, Knight, J

High-resolution genomic profiling of myelodysplasia (MDS) by microarray comparative genomic hybridisation (CGH) Dahkki Esoof, N, Giagounidis, A, Aul, C, Pellagatti, A, Fidler, C, Ellis, P, Langford, C, Killick, S, Boultwood, J, Wainscoat, J

Identification of acquired somatic mutations in the chromatin remodelling factor ATRX in the a thalassaemia myelodysplasia syndrome (ATMDS) Dahkki Gibbons, R, Pellagatti, A, Garrick, D, Wood, W, Malik, N, Ayyub, H, Langford, C, Boultwood, J, Wainscoat, J, Higgs, D

Identification of acquired somatic mutations in the chromatin remodelling factor ATRX in the alpha thalassemia myelodysplasia syndrome (ATMDS). Dahkki Gibbons, R, Pellagatti, A, Garrick, D, Wood, W, Malik, N, Ayyub, H, Langford, C, Boultwood, J, Wainscoat, J, Higgs, D

Identification of acquired somatic mutations in the gene encoding chromatin-remodeling factor ATRX in the alpha-thalassemia myelodysplasia syndrome (ATMDS). Dahkki Gibbons, R, Pellagatti, A, Garrick, D, Wood, W, Malik, N, Ayyub, H, Langford, C, Boultwood, J, Wainscoat, J, Higgs, D

Expression profiling of CD34+cells in patients with myelodysplastic syndromes with and without a del(5q). Dahkki Pellagatti, A, Giagounidis, A, Killick, S, Campbell, L, Wraight, V, Langford, C, Fidler, C, Oscier, D, Aul, C, Wainscoat, J, Boultwood, J

A FUNCTIONAL GENOMICS APPROACH TO THE IDENTIFICATION OF BR :MARKERS OF SURVIVAL IN SEVERE SEPSIS DUE TO COMMUNITY ACQUIRED PNEUMONIA Dahkki Radhakrishinan, J, Svoren, E, Ellis, P, Langford, C, Huttor, P, Davenport, E, Thorpe, A, Gerrard, C, Knight, J, Hinds, C, Investiga, G

Definition of a minimal region of deletion of chromosome 7 in uterine leiomyomas by tiling-path microarray CGH and mutation analysis of known genes in this region. Dahkki Vanharanta, S, Wortham, N, Langford, C, El-Bahrawy, M, van der Spuy, Z, Sjöberg, J, Lehtonen, R, Karhu, A, Tomlinson, I, Aaltonen, L

Gene expression profiling in 5q-syndrome and myelodysplastic syndromes. Dahkki Pellagatti, A, Esoof, N, Watkins, F, Langford, C, Vetrie, D, Campbell, L, Fidler, C, Cavenagh, J, Eagleton, H, Pushkaran, B, Kwan, M, Wainscoat, J, Boultwood, J

Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype. Dahkki Pellagatti, A, Cazzola, M, Giagounidis, A, Malcovati, L, Porta, MG, Killick, S, Campbell, L, Wang, L, Langford, C, Fidler, C, Oscier, D, Aul, C, Wainscoat, J, Boultwood, J

Adventitious changes in long-range gene expression caused by polymorphic structural variation and promoter competition. Dahkki Lower, K, Hughes, J, De Gobbi, M, Henderson, S, Viprakasit, V, Fisher, C, Goriely, A, Ayyub, H, Sloane-Stanley, J, Vernimmen, D, Langford, C, Garrick, D, Gibbons, R, Higgs, D

Gene expression profiling in the myelodysplastic syndromes using cDNA microarray technology. Dahkki Pellagatti, A, Esoof, N, Watkins, F, Langford, C, Vetrie, D, Campbell, L, Fidler, C, Cavenagh, J, Eagleton, H, Gordon, P, Woodcock, B, Pushkaran, B, Kwan, M, Wainscoat, J, Boultwood, J

A comprehensive study of chromosome 16q in invasive ductal and lobular breast carcinoma using array CGH. Dahkki Roylance, R, Gorman, P, Papior, T, Wan, Y, Ives, M, Watson, J, Collins, C, Wortham, N, Langford, C, Fiegler, H, Carter, N, Gillett, C, Sasieni, P, Pinder, S, Hanby, A, Tomlinson, I

Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis Dahkki Wechsler, M, Akuthota, P, Jayne, D, Khoury, P, Klion, A, Langford, C, Merkel, P, Moosig, F, Specks, U, Cid, M, Luqmani, R, Brown, J, Mallett, S, Philipson, R, Yancey, S, Steinfeld, J, Weller, P, Gleich, G

OP0130 Mepolizumab for the treatment of patients with eosinophilic granulomatosis with polyangiitis: a phase iii randomised, placebo-controlled trial Dahkki Wechsler, M, Akuthota, P, Jayne, D, Khoury, P, Klion, A, Langford, C, Merkel, P, Moosig, F, Specks, U, Cid, M, Luqmani, R, Brown, J, Mallett, S, Philipson, R, Yancey, S, Steinfeld, J, Weller, P, Gleich, G